Rod Markin is Associate Vice Chancellor for Business Development and Executive Director of UNeTech Institute at the University of Nebraska Medical Center, where he is also a Professor of Pathology and Microbiology, Surgery, and Psychiatry; and a David T. Purtilo Distinguished Professor of Pathology and Microbiology. His career has included a variety of leadership roles in the University of Nebraska Department of Pathology and Microbiology, including Vice Chair of the department, leader of the UNMC faculty group practice plan, and Dean of the College of Medicine.
Board certified in Anatomic and Clinical Pathology, Markin’s professional and academic research focuses on solid organ transplantation, informatics, and clinical laboratory automation, leading to more than 300 publications and nearly 200 abstracts and chapters in books.
In addition to the KGI Board of Trustees, Markin also serves on the Board of Directors of Prairie Ventures, Cardiff Oncology, Inc., Perceptimed, Afaxys and MikroScan.
Markin holds a BS in chemistry from Nebraska Wesleyan University, a PhD in biochemistry from the University of Nebraska-Lincoln, and a medical degree from UNMC-Omaha.